Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (opens new window)

Ball AM, Winstead PS.

Allikas‎: Pharmacotherapy 2008;28(11):1383-90.

Indekseeritud‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (opens new window)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (opens new window)

Charles A, Purtill M, Napolitano LM.

Allikas‎: Anaesth Intensive Care 2006;34(6):793-6.

Indekseeritud‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (opens new window)

Thalidomide for recurrent bleeding due to small-intestinal angiodysplasia. (opens new window)

Chen H, Wu S, Tang M, Zhao R, Zhang Q, Dai Z, Gao Y, Yang S, Li Z, Du Y, Yang A, Zhong L, Lu L, Xu L, Shen X, Liu S, Zhong J, Li X, Lu H, Xiong H, Shen Y, Chen H, Gong S, Xue H, Ge Z

Allikas‎: N Engl J Med. 2023 2;389(18):1649-59.

Indekseeritud‎: PubMed 37913505

DOI‎: 10.1056/NEJMoa2303706

https://pubmed.ncbi.nlm.nih.gov/37913505/ (opens new window)

Bloodless management of the anemic patient in the emergency department. (opens new window)

Johnson-Arbor K, Verstraete R

Allikas‎: Ann Emerg Med 2022;79(1):48-57.

Indekseeritud‎: PubMed 34353645

DOI‎: 10.1016/j.annemergmed.2021.06.015

https://pubmed.ncbi.nlm.nih.gov/34353645/ (opens new window)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (opens new window)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Allikas‎: J Trauma 2008;65(2):285-97.

Indekseeritud‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (opens new window)

Erythropoiesis in multiply injured patients. (opens new window)

Robinson Y, Hostmann A, Matenov A, Ertel W, Oberholzer A.

Allikas‎: J Trauma 2006;61(5):1285-91.

Indekseeritud‎: PubMed 17099548

DOI‎: 10.1097/01.ta.0000240969.13891.9b

https://www.ncbi.nlm.nih.gov/pubmed/17099548 (opens new window)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (opens new window)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Allikas‎: Arch Surg 2012;147(3):251-5.

Indekseeritud‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (opens new window)

Zeugen Jehovas und Schwerverletzung mit drohender Hämorrhagie. Wie komplex ist die Behandlung? [Jehovah's Witnesses and severe injury with impending hemorrhaging: how complex is the treatment?] [German, English abstract] (opens new window)

Zeckey C, Vanin N, Neitzke G, Mommsen P, Bachmann S, Frink M, Wilhelmi M, Krettek C, Hildebrand F.

Allikas‎: Chirurg 2011;82(6):531-5.

Indekseeritud‎: PubMed 21088815

DOI‎: 10.1007/s00104-010-1999-y

https://www.ncbi.nlm.nih.gov/pubmed/21088815 (opens new window)